{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:35:34Z","timestamp":1761060934371},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,2,18]],"date-time":"2003-02-18T00:00:00Z","timestamp":1045526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Res"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s00240-002-0294-x","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:09:29Z","timestamp":1576120169000},"page":"17-21","source":"Crossref","is-referenced-by-count":5,"title":["Targeting gene expression of the mouse uroplakin II promoter to human bladder cells"],"prefix":"10.1007","volume":"31","author":[{"given":"Hongjian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing A.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangfu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoushun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,2,18]]},"reference":[{"key":"0294_CR1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.91.1.365","volume":"91","author":"Brady","year":"1993","unstructured":"Brady HJ, Miles CG, Pennington DJ, Dzierzak EA (1993) Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci U S A 91: 365","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0294_CR2","unstructured":"Catalona WJ (1992) Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey WJ (eds) Campbell's urology, 6th edn. WB Saunders, Philadelphia, p 1094"},{"key":"0294_CR3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-5347(05)68041-X","volume":"163","author":"Elsasser","year":"2000","unstructured":"Elsasser BU, Gutzeit O, Bauer S, Katzenwadel A, Schultze-Seemann W, Wetterauer U (2000) Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas. J Urol 163: 296","journal-title":"J Urol"},{"key":"0294_CR4","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.165.5.2886","volume":"165","author":"Griffith","year":"2000","unstructured":"Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL (2000) Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand\/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 165: 2886","journal-title":"J Immunol"},{"key":"0294_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0094-0143(05)70238-X","volume":"27","author":"Hsieh","year":"2000","unstructured":"Hsieh JT, Dinney CPN, Chung LWK (2000) The potential role of gene therapy in the treatment of bladder cancer. Urol Clin North Am 27: 103","journal-title":"Urol Clin North Am"},{"key":"0294_CR6","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S (1999) Cancer statistics. CA Cancer J Clin 49: 1999","journal-title":"CA Cancer J Clin"},{"key":"0294_CR7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00005392-199909010-00093","volume":"162","author":"Li","year":"1999","unstructured":"Li SM, Zhang ZT, Chan S, Mclenan O, Dixon C, Taneja S, Lepor H, Sun TT, Wu XR (1999) Detection of circulating Uroplakin\u2013positive cells in patients with transitional cell carcinoma of the bladder. J Urol 162: 931","journal-title":"J Urol"},{"key":"0294_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1073\/pnas.92.3.679","volume":"92","author":"Lin","year":"1995","unstructured":"Lin JH, Zhao H, Sun TT (1995) A tissue specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc Natl Acad Sci U S A 92: 679","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0294_CR9","first-page":"1383","volume":"147","author":"Moll","year":"1995","unstructured":"Moll R, Wu XR, Lin JH, Sun TT (1995) Uroplakins specific membrane proteins of urothelial umbrella cells as histological markers of metastatic transitional cell carcinomas. Am J Pathol 147: 1383","journal-title":"Am J Pathol"},{"key":"0294_CR10","first-page":"190","volume":"9","author":"Nicholas","year":"1990","unstructured":"Nicholas M, Richard V (1990) Targeted vector for gene therapy. FASEBJ 9: 190","journal-title":"FASEBJ"},{"key":"0294_CR11","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1089\/10430340050111331","volume":"11","author":"Oyama","year":"2000","unstructured":"Oyama M, Ohigashi T, Hoshi M, Nakashima J, Tachibana M, Murai M, Uyemura K, Yazaki T (2000) Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207. Hum Gene Ther 11: 1683","journal-title":"Hum Gene Ther"},{"key":"0294_CR12","first-page":"4405","volume":"61","author":"Peng","year":"2001","unstructured":"Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A (2001) The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res 61: 4405","journal-title":"Cancer Res"},{"key":"0294_CR13","first-page":"83","volume":"53","author":"Ram","year":"1993","unstructured":"Ram N, Culver KW, Walberidge S, Blaese RM, Oldfield EH (1993) In situ retrovial-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53:83","journal-title":"Cancer Res"},{"key":"0294_CR14","first-page":"178","volume":"5","author":"Roth","year":"1993","unstructured":"Roth JA (1993) Targeting lung cancer genes: a novel approach to cancer prevention and therapy. Semin Thorac Cardiovasc Surg 5: 178","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"0294_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-5347(17)35014-0","volume":"151","author":"Sandberg","year":"1994","unstructured":"Sandberg AA, Berger CS (1994) Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of blader cancer. J Urol 151: 545","journal-title":"J Urol"},{"key":"0294_CR16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00005392-200102000-00091","volume":"165","author":"Siemens","year":"2001","unstructured":"Siemens DR, Austin JC, See WA, Tartaglia J, Ratliff TL (2001) Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. J Urol 165: 667","journal-title":"J Urol"},{"key":"0294_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00357068","volume":"23","author":"Sun","year":"1996","unstructured":"Sun TT, Zhao H, Provet J, Aebi U, Wu XR (1996) Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep 23: 3","journal-title":"Mol Biol Rep"},{"key":"0294_CR18","doi-asserted-by":"crossref","first-page":"8746","DOI":"10.1073\/pnas.87.22.8746","volume":"87","author":"Venkatesh","year":"1990","unstructured":"Venkatesh LK, Arens MQ, Subramanian T, Chinnadurai G (1990) Selective induction of toxicity to human cells expressing human immunodeficiency virus type I Tat by a conditionally cytotoxic adenovirus vector. Proc Natl Acad Sci U S A 87: 8746","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0294_CR19","first-page":"962","volume":"53","author":"Vile","year":"1993","unstructured":"Vile RG, Hart IR (1993) In vitro and in vivo targeting gene of gene expression to melanoma cells. Cancer Res 53: 962","journal-title":"Cancer Res"},{"key":"0294_CR20","doi-asserted-by":"crossref","first-page":"19170","DOI":"10.1016\/S0021-9258(17)30640-3","volume":"265","author":"Wu","year":"1990","unstructured":"Wu XR, Manabe M, Yu J, Sun TT (1990) Large scale purification and immunolocalization of bovine Uroplakin I II and III. J Biol Chem 265: 19170","journal-title":"J Biol Chem"},{"key":"0294_CR21","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1016\/S0021-9258(17)36889-8","volume":"269","author":"Wu","year":"1994","unstructured":"Wu XR, Lin JH, Thomas W, Haner M, Yu J, Aebi U,Sun TT (1994) Mammalian uroplakins, a group of highly conserved urothelial differentiation related membrane proteins. J Biol Chem 269: 13716","journal-title":"J Biol Chem"},{"key":"0294_CR22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","volume":"164","author":"Yamada","year":"2000","unstructured":"Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U (2000) Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2. J Urol 164: 526","journal-title":"J Urol"},{"key":"0294_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1046\/j.1442-2042.1999.00064.x","volume":"6","author":"Yuasa","year":"1999","unstructured":"Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y (1999) Expression of transitional cell specific genes uroplakin Ia and II in bladder cancer detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol 6: 286","journal-title":"Int J Urol"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-002-0294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-002-0294-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-002-0294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T19:27:37Z","timestamp":1613071657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-002-0294-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["0294"],"URL":"https:\/\/doi.org\/10.1007\/s00240-002-0294-x","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,18]]}}}